MeSHDD: Literature-based drug-drug similarity for drug repositioning

被引:32
|
作者
Brown, Adam S. [1 ]
Patel, Chirag J. [1 ]
机构
[1] Harvard Med Sch, Dept Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA
关键词
drug repositioning; similarity; MeSH terms; PubMed; metformin; WIDE ASSOCIATION; CONNECTIVITY MAP; DISEASE; TARGET; IDENTIFICATION; DISCOVERY; METFORMIN; RESOURCE; DATABASE;
D O I
10.1093/jamia/ocw142
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Drug repositioning is a promising methodology for reducing the cost and duration of the drug discovery pipeline. We sought to develop a computational repositioning method leveraging annotations in the literature, such as Medical Subject Heading (MeSH) terms. Methods: We developed software to determine significantly co-occurring drug-MeSH term pairs and a method to estimate pair-wise literature-derived distances between drugs. Results We found that literature-based drug-drug similarities predicted the number of shared indications across drug-drug pairs. Clustering drugs based on their similarity revealed both known and novel drug indications. We demonstrate the utility of our approach by generating repositioning hypotheses for the commonly used diabetes drug metformin. Conclusion: Our study demonstrates that literature-derived similarity is useful for identifying potential repositioning opportunities. We provided open-source code and deployed a free-to-use, interactive application to explore our database of similarity-based drug clusters (available at http://apps.chiragjpgroup.org/MeSHDD/).
引用
收藏
页码:614 / 618
页数:5
相关论文
共 50 条
  • [1] Literature-based drug-drug similarity for drug repurposing: impact of Medical Subject Headings term refinement and hierarchical clustering
    Das, Shyam Sundar
    Ranjan, Pritish
    Kunnakkattu, Ibrahim Roshan
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (18) : 1309 - 1323
  • [2] Prioritizing Adverse Drug Reaction and Drug Repositioning Candidates Generated by Literature-Based Discovery
    Rastegar-Mojarad, Majid
    Elayavilli, Ravikumar Komandur
    Wang, Liwei
    Prasad, Rashmi
    Liu, Hongfang
    PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, 2016, : 289 - 296
  • [3] Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
    Qin, Shimei
    Li, Wan
    Yu, Hongzheng
    Xu, Manyi
    Li, Chao
    Fu, Lei
    Sun, Shibin
    He, Yuehan
    Lv, Junjie
    He, Weiming
    Chen, Lina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [4] A new method for prioritizing drug repositioning candidates extracted by literature-based discovery
    Rastegar-Mojarad, Majid
    Elayavilli, Ravikumar Komandur
    Li, Dingcheng
    Prasad, Rashmi
    Liu, Hongfang
    PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE, 2015, : 669 - 674
  • [5] Measuring drug similarity using drug-drug interactions
    Lv, Ji
    Liu, Guixia
    Ju, Yuan
    Huang, Houhou
    Sun, Ying
    QUANTITATIVE BIOLOGY, 2024, 12 (02) : 164 - 172
  • [6] Drug Repositioning Based on Deep Sparse Autoencoder and Drug–Disease Similarity
    Song Lei
    Xiujuan Lei
    Ming Chen
    Yi Pan
    Interdisciplinary Sciences: Computational Life Sciences, 2024, 16 : 160 - 175
  • [7] Drug and disease similarity calculation platform for drug repositioning
    Huang, Lan
    Luo, HuiMin
    Yang, Mengyun
    Wu, Fang-Xiang
    Wang, Jianxin
    2019 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2019, : 124 - 129
  • [8] Drug-drug similarity measure and its applications
    Huang, Lan
    Luo, Huimin
    Li, Suning
    Wu, Fang-Xiang
    Wang, Jianxin
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (04)
  • [9] Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity
    Shao, Mengting
    Jiang, Leiming
    Meng, Zhigang
    Xu, Jianzhen
    MOLECULES, 2022, 27 (04):
  • [10] Uncovering New Drug Properties in Target-Based Drug-Drug Similarity Networks
    Udrescu, Lucretia
    Bogdan, Paul
    Chis, Aimee
    Sirbu, Ioan Ovidiu
    Topirceanu, Alexandru
    Varut, Renata-Maria
    Udrescu, Mihai
    PHARMACEUTICS, 2020, 12 (09) : 1 - 27